Literature DB >> 18277924

Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

C Buddy Creech1, Susan E Beekmann, YiYi Chen, Philip M Polgreen.   

Abstract

There are currently no clear consensus recommendations for the treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in pediatric patients. We surveyed over 100 Pediatric Infectious Diseases consultants and found considerable variability in both the treatment of skin and soft tissue infections and the strategies used for the management of children with recurrent MRSA disease.

Entities:  

Mesh：

Year:  2008        PMID： 18277924     DOI： 10.1097/INF.0b013e31815c9068

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  18 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Molecular epidemiology of Staphylococcus aureus in households of children with community-associated S aureus skin and soft tissue infections.

Authors:  Marcela Rodriguez; Patrick G Hogan; Carey-Ann D Burnham; Stephanie A Fritz
Journal:  J Pediatr       Date:  2013-10-13       Impact factor: 4.406

3.  Topical Decolonization Does Not Eradicate the Skin Microbiota of Community-Dwelling or Hospitalized Adults.

Authors:  C A Burnham; Patrick G Hogan; Meghan A Wallace; Elena Deych; William Shannon; David K Warren; Stephanie A Fritz
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Antibiotic Duration, but Not Abscess Size, Impacts Clinical Cure of Limited Skin and Soft Tissue Infection After Incision and Drainage.

Authors:  Jason G Lake; Loren G Miller; Stephanie A Fritz
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

5.  Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers.

Authors:  Kara B Mascitti; Jeffrey S Gerber; Theoklis E Zaoutis; Todd D Barton; Ebbing Lautenbach
Journal:  Am J Infect Control       Date:  2010-05       Impact factor: 2.918

6.  Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Authors:  Stephanie A Fritz; Patrick G Hogan; Bernard C Camins; Ali J Ainsworth; Carol Patrick; Madeline S Martin; Melissa J Krauss; Marcela Rodriguez; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

7.  The natural history of contemporary Staphylococcus aureus nasal colonization in community children.

Authors:  Stephanie A Fritz; Melissa J Krauss; Emma K Epplin; Carey-Ann Burnham; Jane Garbutt; W Michael Dunne; David A Hunstad; Gregory A Storch
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

8.  Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.

Authors:  Stephanie A Fritz; Bernard C Camins; Kimberly A Eisenstein; Joseph M Fritz; Emma K Epplin; Carey-Ann Burnham; Jonathan Dukes; Gregory A Storch
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09       Impact factor: 3.254

9.  Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial.

Authors:  Stephanie A Fritz; Patrick G Hogan; Genevieve Hayek; Kimberly A Eisenstein; Marcela Rodriguez; Emma K Epplin; Jane Garbutt; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2011-12-23       Impact factor: 9.079

10.  Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.

Authors:  Michele J Anderson; Maren L David; Matt Scholz; Sally J Bull; Dan Morse; Michelle Hulse-Stevens; Marnie L Peterson
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.